Do cures harm the drug business?

OTTAWA: "Is curing patients a sustainable business model?" That provocative question was posed on page 38 of a Goldman Sachs research report...

PPMA strongly refutes allegations against quality of Pakistani medicines

Pharmaceutical body defends industry standards, warns against harmful impact on exports and national reputation

Citi Pharma submits offers for acquisition of leading pharma company 

Non-binding offer is part of Citi’s strategic expansion plans to become largest pharma firm 

Sanofi-Aventis Pakistan’s sole shareholder to transfer its shareholding to subsidiary Zentiva NV

LAHORE: Sanofi-Aventis Pakistan (Ltd) on Friday announced that the sole shareholder of SECIPE, i.e. Sanofi S.A. has made a decision to disincorporate...

PPMA vs DRAP: Pharma crisis continues 

Unavailability of medicines could inevitably trigger national health emergency

Citi Pharma enters into supply agreement with India’s Murli Krishna Pharma 

Murli Krishna Pharma will supply high-quality Active Pharmaceutical Ingredients (APIs) and products exclusively to Citi Pharma in Pakistan
Medicines

Customs seizes smuggled Indian-origin medicines worth Rs10.3bn in Karachi

Investigation launched against two pharmaceutical companies over illegal drug trade

Govt takes away drug pricing power from pharmaceutical companies 

ISLAMABAD: The federal government has put an end to the power of pharmaceutical companies to increase prices of drugs while not paying...

Pharma sector earnings rise 3.1x to Rs24.8bn in 2024, driven by 15% rise in net sales

Net sales reach Rs318bn, gross margins improve to 36%, while finance costs rise to Rs8bn in 2024; deregulation of drug prices boosts profitability.

Pakistan’s medicinal imports rise by 9.74pc

ISLAMABAD: Pakistan imported medicinal product worth $656.092 million during the first seven months of current fiscal year, showing growth of 9.74 per...

Pharma industry protests govt’s refusal to increase drug prices

LAHORE: The Ministry of National Health Service Regulations and Coordination on Monday announced that there will be no immediate increase in drug...

The mechanics behind the panadol shortage

Raids, hoarding and over regulating — You probably need a Panadol to figure out what’s going on

Pfizer looks beyond COVID sales with $43b deal for cancer drugmaker Seagen

WASHNGTON: Pfizer Inc on Monday struck a roughly $43 billion deal for Seagen Inc to bulk up its cancer treatments portfolio, as...

Citi Pharma ventures into direct marketing sector

Company aims to improve medicine accessibility and expand globally

PSW, DRAP launch digital certificates to boost pharmaceutical exports 

Alongside Digital Certificate of Pharmaceutical Product, DRAP Clearance Gateway now offers Free Sale Certificate, Good Manufacturing Practice Certificate, and No Objection Certificate for exports; initiative to enhance regulatory efficiency